# OnCo record paper-ferraldeschi-pten-protein-loss-abiraterone-eur-urol-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ferraldeschi-pten-protein-loss-abiraterone-eur-urol-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ferraldeschi-pten-protein-loss-abiraterone-eur-urol-2015" ;
  schema:name "PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate"@en ;
  schema:description "Staining tumour samples from 144 men showed that the 40% who had lost a particular protein lived about seven months less on abiraterone."@en ;
  schema:url <https://onco.cc/key-papers/paper-ferraldeschi-pten-protein-loss-abiraterone-eur-urol-2015/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.eururo.2014.10.027>, <https://pubmed.ncbi.nlm.nih.gov/25454616/> ;
  schema:sameAs <https://doi.org/10.1016/j.eururo.2014.10.027> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Ferraldeschi R, Nava Rodrigues D, Riisnaes R, et al." ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/histopathology-ihc/> ;
  onco:targets <https://onco.cc/targets/pten/>, <https://onco.cc/targets/akt/> ;
  onco:drugs <https://onco.cc/drugs/abiraterone/> ;
  onco:pathways <https://onco.cc/pathways/pi3k-akt-mtor/>, <https://onco.cc/pathways/ar-signaling/> ;
  onco:terms <https://onco.cc/terms/ihc/>, <https://onco.cc/terms/castration-resistance/>, <https://onco.cc/terms/resistance/> ;
  onco:journals <https://onco.cc/journals/european-urology/> .